Biomarkers in Alzheimers Disease, 2011 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Biomarkers in Alzheimers Disease, 2011

Description:

This report provides an overview of biomarkers associated with Alzheimer’s disease (AD) that have potential in differential diagnosis, in following treatment, in clinical trials and drug discovery. These include molecules found in CSF and blood, genotypes, image-based parameters and others. – PowerPoint PPT presentation

Number of Views:348

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Biomarkers in Alzheimers Disease, 2011


1
Aarkstore.com Biomarkers in Alzheimers Disease,
2011
2
Summary
  • This report provides an overview of biomarkers
    associated with Alzheimers disease (AD) that
    have potential in differential diagnosis, in
    following treatment, in clinical trials and drug
    discovery. These include molecules found in CSF
    and blood, genotypes, image-based parameters and
    others. AD biomarkers offer utility in a number
    of ways identification of groups at risk of
    developing AD early detection of AD
    differentiation of different forms of
    neurodegenerative disease from AD, as well as
    developmental stages (such as MCI), thought to
    progress to AD supporting specific treatments or
    pharmacological interventions following the
    time-course progression of AD and response to
    therapy assessing patient prognosis advancing
    understanding of the disease, including risk
    factors, and the changes that precede its
    development the identification of new drug
    targets and candidate molecules development of
    discovery assays for efficacy or toxicity
    markers and supporting the recruitment of
    subjects most likely to provide a meaningful
    analysis of treatment effects. These areas are,
    therefore, considered and discussed in relation
    to the AD biomarkers presented in this report.

3
Table of Contents
  • Chapter 1 Background p.251. Alzheimers Disease
    1.1 Statistics and Costs 1.2 Histopathology
    1.3 Amyloid Beta (Abeta) 1.4 Tau Proteins and
    Neurofibrillary Tangles 1.5 Cholinergic
    Hypothesis 1.6 Diagnosis 1.7 Cognitive Tests
    1.8 Stages of Alzheimers Disease 1.9 Treatment
    of AD 1.10 Biomarkers 1.11 Genetics 1.12
    Autoantibodies1.13 Blood Brain Barrier1.14
    Pathogenesis of Alzheimers diseaseReferences
    (Chapter 1)

4
More Related Reports
  •   VEGF Inhibition Therapy-Indicating and
    Prognostic Biomarkers, 2011
  •   Biomarkers in Alzheimers Disease, 2011
  •   Alzheimers Disease Autoantibodies, Vaccines
    and Therapeutic Antibodies Pipeline, 2011
  •   Prostate Cancer Vaccines and Therapeutic
    Antibodies Pipeline, 2011
  •   Breast Cancer Vaccines and Therapeutic
    Antibodies Pipeline, 2011
  •   Alzheimers Disease Biomarkers in Cerebrospinal
    Fluid and Blood, 2011
  •   Image-Based Biomarkers in Alzheimers Disease,
    2011
  •   Lung Cancer Vaccines and Therapeutic
    Antibodies Pipeline, Strategies and Clinical

5
For More details
  • http//www.aarkstore.com/reports/Biomarkers-in-Alz
    heimers-Disease-2011-146428.html
  • Vina
  • Aarkstore.com
  • Contact Marketing team
  • Mob.No.918149852585
  • Email enquiry_at_aarkstore.com
  • URL http//www.aarkstore.com/
  • XML http//www.aarkstore.com/feeds/Biopharmrepor
    ts.xml
About PowerShow.com